Filing summary
Entity identification: The request names Olenox Industries Inc., but the supplied Form 10-K is for Safe & Green Holdings Corp. (Nasdaq: SGBX). Confirm that this is the intended filing before relying on the summary.
Business context and reporting period
This is Safe & Green Holdings Corp.’s audited Form 10-K for the fiscal year ended December 31, 2022, compared with 2021. The company operates in modular construction, medical testing, real estate development, and environmental services. Its manufacturing subsidiary, SG Echo, produces modular buildings; real estate and environmental activities were early-stage, with no revenue reported from SG DevCorp. or SG Environmental in 2022.
Key financial metrics
| Metric | 2022 | 2021 |
|---|---|---|
| Revenue | $24.4 million | $38.3 million |
| Gross profit / margin | $3.3 million / 13.3% | $2.3 million / 6.1% |
| Operating loss | $7.2 million | $6.0 million |
| Net loss | $7.1 million | $5.9 million |
| Net loss attributable to Safe & Green common stockholders | $8.3 million | $10.8 million |
| Cash used in operating activities | $5.6 million | $0.7 million |
| Cash and cash equivalents at year-end | $0.6 million | $13.0 million |
| Total liabilities | $12.1 million | $13.2 million |
| Stockholders’ equity | $14.4 million | $21.7 million |
Medical revenue was $11.6 million, down 63%, mainly reflecting reduced COVID-19 testing. Construction and engineering revenue was approximately $12.8 million, up 88%. Construction’s gross profit was negative, while medical operations generated $2.6 million of operating income. Corporate and support recorded a $7.2 million operating loss; development recorded a $2.1 million operating loss. The environmental segment had no activity.
Year-end current assets were $7.5 million and current liabilities were $8.3 million, including a $2.6 million short-term note payable. The filing reports approximately $820,000 of negative working capital. Long-term notes payable were $750,000; lease liabilities totaled approximately $4.3 million. Cash-flow investing activities used $3.9 million, and financing activities used $3.0 million.
Material changes versus 2021
- Revenue fell 36%, as the sharp decline in medical/testing revenue outweighed construction growth.
- Gross profit and gross margin improved, but the operating loss widened 21% to $7.2 million, with higher payroll, corporate overhead, and development costs.
- Operating cash use increased to $5.6 million, and cash declined by $12.4 million to $0.6 million, following substantial cash use and investment during 2022.
- The Clarity Mobile medical joint venture was wound down by mutual agreement in September 2022 as COVID testing demand weakened.
- Construction backlog rose to $6.8 million from $3.2 million, primarily due to a $5.8 million contract signed in 2022.
Outlook, risks, contingencies, and unusual items
- Going concern: The auditor highlighted substantial doubt about the company’s ability to continue as a going concern, citing recurring losses, negative operating cash flow, and a working-capital deficiency. Management says it may need additional capital; no future funding source was secured at year-end.
- Backlog and execution: Management expected all $6.8 million of year-end construction backlog to convert to revenue by December 31, 2023. Backlog can be cancelled or changed, and conversion and profitability are not assured.
- Financing after year-end: On February 7, 2023, the company issued a $1.1 million-principal, 8% convertible debenture for $1.0 million gross proceeds, plus a warrant for up to 500,000 shares. The debenture has a 12-month maturity and anti-dilution provisions, including a $0.40 floor subject to shareholder approval for lower-priced issuance. A separate proposed $5.0 million property-secured refinancing had not closed as of the report date.
- Development and separation plans: SG DevCorp. projects and a proposed separation into two public companies depend on financing, approvals, construction, and market conditions. The separation was not assured of completion. Project cost and timing estimates in the filing are plans, not guaranteed outcomes.
- Unusual income and estimates: 2022 other income included acquisition-escrow proceeds, legal settlement income, and write-offs of accounts payable; the filing also reports a $1.07 million direct write-off of accounts receivable in the cash-flow reconciliation. Construction revenue recognized over time depends on estimates of costs to complete, identified by the auditor as a critical audit matter. No goodwill impairment was recorded.
- Legal matters: The company disclosed ongoing litigation, including the Osang dispute and a claim involving EDI International. The HOLA action was settled and dismissed in February 2023. The company said it could not estimate potential losses or recoveries for certain matters.
- Concentration and other risks: Three customers represented approximately 65% of 2022 revenue, and three customers accounted for 80% of year-end gross receivables. Risks also include dilution, limited authorized shares, project cancellations, customer financing, construction costs and delays, and Nasdaq listing and stock-price volatility.
Most important facts to verify
- Confirm that Safe & Green Holdings Corp.’s filing—not Olenox Industries Inc.’s—is the intended filing.
- Review the auditor’s going-concern paragraph, negative working capital, and the company’s cash runway and financing needs.
- Check the terms, registration status, conversion and dilution effects of the February 2023 debenture and warrant, and whether the proposed $5.0 million refinancing closed.
- Track whether the $6.8 million backlog converts to revenue and at what margins, particularly the large 2022 contract.
- Assess progress, funding, approvals, costs, and timing for SG DevCorp.’s developments and proposed separation; verify whether SG Environmental begins generating revenue.
- Review customer concentration, receivable collectability, construction cost-to-complete estimates, and the status and potential exposure of disclosed litigation.